SAB Biotherapeutics News

8-K: Current report

Sep 9 20:25

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 13 05:16

8-K: Current report

Jul 31 20:01

8-K: Current report

Jun 28 05:33

8-K: Current report

Jun 1 01:23

DEF 14A: Definitive information statements

May 31 05:18

8-K: Current report

May 21 19:35

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 16 04:40

8-K: Current report

May 9 01:32

SAB Biotherapeutics | 8-K: Current report

Apr 16 05:20

SAB Biotherapeutics | 8-K: Current report

Mar 29 21:37

SAB Biotherapeutics | 8-K: Current report

Mar 9 05:31

SAB Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 24 11:18

SAB Biotherapeutics | 8-K: Current report

Feb 2 20:55

SAB Biotherapeutics | 8-K: Current report

Jan 27 05:22

SAB Biotherapeutics | 8-K: Current report

Jan 26 06:08

SAB Biotherapeutics | 8-K: Current report

Jan 19 13:00

SAB Biotherapeutics | 8-K: Current report

Jan 3 13:00

SAB Biotherapeutics | DEF 14A: Definitive information statements

Dec 18, 2023 22:34

SAB Biotherapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Dec 9, 2023 06:26